Wednesday, May 20, 2009

Novartis buy Ebewe

Novartis said it was buying the injectable generic cancer drugs business of Austrian Ebewe Pharma for €925m ($1.3bn) in cash to boost its copycat medicine unit Sandoz.
More

No comments: